AMCR vs TERN · P/E 18, $22.52B cap vs $6.12B cap
Amcor PLC (AMCR) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
AMCR does not have a complete income-statement cache yet.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. TERN currently screens at market cap $6.12B.
Not investment advice. Open the AMCR and TERN stock pages for the full models.
Not investment advice.